SCHEMBL22041628

SCHEMBL22041628

O=C(Oc1c(Cl)c(Cl)cc2cc(C(=O)O)c(=O)oc12)c1ccco1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 10/20 0.47
▸ HPGD P15428 4/20 0.47
▸ CASP1 P29466 3/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ ALOX12 P18054 2/20 0.47
▸ USP2 O75604 2/20 0.47
▸ CASP7 P55210 2/20 0.47
▸ POLB P06746 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ ALDH1A1 P00352 4/20 0.42
▸ MAPT P10636 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ HTT P42858 1/20 0.42
▸ CCR6 P51684 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ MAOA P21397 1/20 0.42
▸ KMT2A Q03164 5/20 0.42
▸ GAA P10253 3/20 0.42
▸ KDM4E B2RXH2 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22041620 0.82 GPR35 (0.53) GPR35HPGDCASP1HSD17B10USP2
SCHEMBL22041595 0.81 GPR35 (0.47) GPR35HPGDCASP1HSD17B10ALOX12
SCHEMBL22041598 0.80 GPR35 (0.55) GPR35HPGDCASP1HSD17B10ALOX12
SCHEMBL22041627 0.76 ALDH1A1 (0.58) GPR35HSD17B10ALDH1A1MAPTMAOA
SCHEMBL22041606 0.71 GPR35 (0.71) GPR35HPGDCASP1HSD17B10ALOX12
SCHEMBL22041599 0.70 GPR35 (0.52) GPR35HPGDCASP1HSD17B10ALOX12
SCHEMBL18306420 0.67 MAOA (0.71) GPR35HPGDCASP1HSD17B10ALOX12
SCHEMBL22041589 0.67 GPR35 (0.50) GPR35HPGDCASP1HSD17B10ALOX12
SCHEMBL9068668 0.65 GPR35 (1.00) GPR35HPGDCASP1HSD17B10ALOX12
SCHEMBL11536342 0.65 MAOA (0.66) GPR35HPGDHSD17B10POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 — — WO claimed
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 — — WO disclosed
Send feedback